Table 1.
Antiproliferative activity of β-Carbolines on human colon and pancreatic cancer cell lines.
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound No. | R1 | R2 | R3 | R4 | R5 | R6 | R7 | X | HCT116 (CCa) IC50 (µM) |
HPAC (PCb) IC50 (µM) |
Mia- PaCa2 (PCb) IC50 (µM) |
Panc-1 (PCb) IC50 (µM) |
| 1 |
|
H | H | H | H | OCH3 | H | NH | 7.0 | NDc | ND | ND |
| 2 |
|
H | H | H | OCH3 | H | H | NH | 0.51 | 0.56 | 0.49 | 0.58 |
| 3 |
|
H | H | H | H | OCH3 | H | NH | ND | 34.77 | 49.17 | >50.00 |
| 4 |
|
H | H | H | OCH3 | H | H | NH | 26.10 | >50.00 | >50.00 | >50.00 |
| 5 |
|
H | H | H | H | OCH3 | H | NH | 49.60 | >50.00 | >50.00 | >50.00 |
| 6 |
|
H | H | H | OCH3 | H | H | NH | >50.00 | 45.11 | 38.28 | >50.00 |
| 7 |
|
H | H | H | OCH3 | H | H | NH | 5.70 | 7.37 | 4.70 | 10.46 |
| 8 |
|
H | H | H | H | OCH3 | H | NH | 33.50 | 44.88 | 36.73 | >50.00 |
| 9 |
|
H | H | H | OCH3 | H | H | NH | 14.10 | 21.88 | 17.02 | 28.96 |
| 10 |
|
H | H | H | H | OCH3 | H | NH | 13.10 | 14.45 | 16.72 | 37.21 |
| 11 |
|
H | H | H | OCH3 | H | H | NH | 0.13 | 0.29 | 0.20 | 0.29 |
| 12 |
|
H | H | H | H | OCH3 | H | NH | 3.60 | 25.54 | 6.61 | >50.00 |
| 13 |
|
H | H | H | OCH3 | H | H | NH | 0.90 | 5.83 | 2.58 | 7.52 |
| 14 |
|
H | H | H | H | OCH3 | H | NH | 12.80 | >50.00 | 28.55 | >50.00 |
| 15 |
|
H | H | H | OCH3 | H | H | NH | 9.00 | 15.92 | 9.81 | 21.20 |
| 16 |
|
H | H | H | H | OCH3 | H | NH | 15.10 | 34.40 | 24.06 | >50.00 |
| 17 |
|
H | H | H | OCH3 | H | H | NH | 0.67 | 5.57 | 1.36 | 8.40 |
| 18 |
|
H | H | H | H | OCH3 | H | NH | 17.10 | 20.76 | 21.68 | 48.03 |
| 19 |
|
H | H | H | OCH3 | H | H | NH | 2.10 | 6.08 | 2.43 | 10.49 |
| 20 |
|
H | H | H | H | OCH3 | H | NH | 1.70 | 5.47 | 3.59 | 14.94 |
| 21 |
|
H | H | H | OCH3 | H | H | NH | 0.53 | 0.54 | 0.84 | 17.97 |
| 22 |
|
H | H | H | H | OCH3 | H | NH | 0.87 | 5.67 | 1.57 | >50.00 |
| 23 |
|
H | H | H | OCH3 | H | H | NH | 33.50 | 44.79 | 37.05 | >50.00 |
| 24 |
|
H | H | H | H | OCH3 | H | NH | 31.40 | 34.27 | 34.30 | >50.00 |
| 25 |
|
H | H | H | OCH3 | H | H | NH | 1.80 | 9.38 | 2.23 | 19.76 |
| 26 |
|
H | H | H | H | OCH3 | H | NH | 2.43 | 17.63 | 20.74 | 33.28 |
| 27 |
|
H | H | H | OCH3 | H | H | NH | 2.22 | 23.12 | 47.19 | >50.00 |
| 28 |
|
H | H | H |
|
H | H | NH | ND | 0.83 | 0.51 | 0.57 |
| 29 |
|
H | H | H | H | H | CH3 | NH | 2.60 | 6.39 | 3.54 | >50.00 |
| 30 |
|
H | H | H | OCH3 | H | H | NH | 3.00 | 17.03 | 48.40 | 47.35 |
| 31 |
|
H | H | H | H | H | OCH3 | NH | ND | 20.54 | 31.90 | 26.49 |
| 32 |
|
H | H | H | OH | H | H | NH | ND | ND | ND | ND |
| 33 |
|
H | Ph | H | OCH3 | H | H | NH | ND | 7.72 | 3.63 | >10 |
| 34 |
|
H | H | H |
|
H | H | NH | ND | 3.83 | 0.58 | 6.11 |
| 35 |
|
H | H | CH3 | H | H | H | NH | ND | 4.03 | 1.17 | 4.56 |
| 36 |
|
H | H | H | OCH3 | H | H | NH | ND | 2.37 | 0.33 | 2.56 |
| 37 |
|
H | H | H | OCH3 | H | H | NH | ND | 6.18 | 1.17 | 2.92 |
| 38 |
|
H | H | H | CH3 | H | H | NH | ND | >50.00 | 41.67 | >50.00 |
| 39 |
|
H | H | H | OCH3 | H | H | NH | ND | 4.79 | 2.95 | >50.00 |
| 40 |
|
H | H | H | Cl | H | H | S | ND | 49.97 | 13.50 | >50.00 |
| 41 |
|
H | H | H | H | H | H | O | ND | >50.00 | 33.59 | >50.00 |
| 42 |
|
H | H | H | H | H | H | S | ND | >50 | >50 | >50 |
| 43 |
|
H | H | H | H | H | H | NH | ND | 2.470 | 1.70 | 9.83 |
| 44 |
|
H | H | H | CH3 | H | H | NH | ND | >50 | 13.08 | >50 |
| 45 |
|
H | H | H | OCF3 | H | H | NH | ND | 35.48 | 8.63 | >50 |
| 46 |
|
H | H | H | CN | H | H | NH | ND | >50.00 | 40.41 | >50 |
| 47 |
|
CO2Et | H | H | OCH3 | H | H | NH | ND | 12.86 | 17.52 | 23.28 |
| 48 |
|
H | H | H | H | H | H | NCH3 | ND | 21.23 | 37.35 | 33.86 |
| 49 |
|
H | H | H | OCH3 | H | H | NCH3 | ND | 44.19 | 34.02 | 41.27 |
CC = Colon cancer;
PC = Pancreatic cancer;
ND = Not determined